Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada

View source ↗

Summary

EMA outlines measures to minimise serious side effects associated with Lemtrada (alemtuzumab) for multiple sclerosis, focusing on safety monitoring and risk mit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Lemtrada (alemtuzumab)